In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake

Journal of Physiology

Volumn 589, Issue 8, 2011, Pages 2041-2054

  Gorres, Brittany K ^a   Bomhoff, Gregory L ^a   Morris, Jill K ^a   Geiger, Paige C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ESTRADIOL BLOOD LEVEL; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; GLUCOSE TRANSPORT; HORMONE ACTION; IN VITRO STUDY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SOLEUS MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; INJECTIONS, SUBCUTANEOUS; INSULIN; MUSCLE, SKELETAL; NITRILES; OVARIECTOMY; PHOSPHORYLATION; PROPIONATES; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 79954461307     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.199018     Document Type: Article

References (61)

1. Alonso A, Fernandez R, Moreno M, Ordonez P, Gonzalez-Pardo H et al (2006). Positive effects of 17β-estradiol on insulin sensitivity in aged ovariectomized female rats. J Gerontol A Biol Sci Med Sci 61, 419-426.
2. Arnold SF, Obourn JD, Jaffe H & Notides AC (1995a). Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol Endocrinol 9, 24-33.
3. Arnold SF, Obourn JD, Yudt MR, Carter TH & Notides AC (1995b). In vivo and in vitro phosphorylation of the human estrogen receptor. J Steroid Biochem Mol Biol 52, 159-171.
4. Baltgalvis KA, Greising SM, Warren GL & Lowe DA (2010). Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle. PLoS One 5, e10164.
5. Barros RP, Gabbi C, Morani A, Warner M & Gustafsson JA (2009). Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab 297, E124-E133.
6. Barros RP, Machado UF & Gustafsson JA (2006a). Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12, 425-431.
7. Barros RP, Machado UF, Warner M & Gustafsson JA (2006b). Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc Natl Acad Sci U S A 103, 1605-1608.
8. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL et al (2006). Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49, 588-597.
9. Carr MC (2003). The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88, 2404-2411.
10. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA & Mackintosh C (2008). Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 409, 449-459.
11. D'Eon TM, Rogers NH, Stancheva ZS & Greenberg AS (2008). Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes. Obesity (Silver Spring) 16, 1284-1288.
12. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M & Wahren J (1985). Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76, 149-155.
13. Deng JY, Hsieh PS, Huang JP, Lu LS & Hung LM (2008). Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 57, 1814-1823.
14. Deroo BJ & Korach KS (2006). Estrogen receptors and human disease. J Clin Invest 116, 561-570.
15. Donahue RP, Bean JA, Donahue RA, Goldberg RB & Prineas RJ (1997). Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care 20, 1670-1676.
16. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
17. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF & Katzenellenbogen BS (2003). Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. Endocrinology 144, 3159-3166.
18. Geiger PC, Han DH, Wright DC & Holloszy JO (2006). How muscle insulin sensitivity is regulated: testing of a hypothesis. Am J Physiol Endocrinol Metab 291, E1258-E1263.
19. Geraghty KM, Chen S, Harthill JE, Ibrahim AF, Toth R, Morrice NA et al (2007). Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochem J 407, 231-241.
20. Gorres BK, Bomhoff GL, Gupte AA & Geiger PC (2011). Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet. J Appl Physiol Jan 13, E-Pub.
21. Gupte AA, Bomhoff GL & Geiger PC (2008). Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J Appl Physiol 105, 839-848.
22. Haim S, Shakhar G, Rossene E, Taylor AN & Ben-Eliyahu S (2003). Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J Endocrinol Invest 26, 1013-1022.
23. Harris HA, Katzenellenbogen JA & Katzenellenbogen BS (2002). Characterization of the biological roles of the estrogen receptors, ERα and ERα, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143, 4172-4177.
24. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB & Cooke PS (2000). Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci U S A 97, 12729-12734.
25. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J et al (2007). Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87, 905-931.
26. Henriksen EJ & Holloszy JO (1991). Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro. Acta Physiol Scand 143, 381-386.
27. Hurn PD & Macrae IM (2000). Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20, 631-652.
28. Joel PB, Traish AM & Lannigan DA (1998). Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273, 13317-13323.
29. Kalbe C, Mau M, Wollenhaupt K & Rehfeldt C (2007). Evidence for estrogen receptor a and b expression in skeletal muscle of pigs. Histochem Cell Biol 127, 95-107.
30. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ et al (2004). Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β. Mol Biol Cell 15, 1262-1272.
31. Kumagai S, Holmang A & Bjorntorp P (1993). The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149, 91-97.
32. Le Goff P, Montano MM, Schodin DJ & Katzenellenbogen BS (1994). Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269, 4458-4466.
33. Lee GS, Kim HJ, Jung YW, Choi KC & Jeung EB (2005). Estrogen receptor α pathway is involved in the regulation of Calbindin-D9k in the uterus of immature rats. Toxicol Sci 84, 270-277.
34. Lindheim SR, Buchanan TA, Duffy DM, Vijod MA, Kojima T, Stanczyk FZ & Lobo RA (1994). Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig 1, 150-154.
35. Louet JF, LeMay C & Mauvais-Jarvis F (2004). Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6, 180-185.
36. Lundholm L, Bryzgalova G, Gao H, Portwood N, Falt S, Berndt KD et al (2008). The estrogen receptor α-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J Endocrinol 199, 275-286.
37. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C et al (2004). Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47, 1175-1187.
38. Matthews J & Gustafsson JA (2003). Estrogen signaling: a subtle balance between ERα and ERβ. Mol Interv 3, 281-292.
39. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS & Katzenellenbogen JA (2001). Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44, 4230-4251.
40. Migliaccio A, Rotondi A & Auricchio F (1986). Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody. EMBO J 5, 2867-2872.
41. Moreno M, Ordonez P, Alonso A, Diaz F, Tolivia J & Gonzalez C (2010). Chronic 17β-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging. Age (Dordr) 32, 1-13.
42. Muraki K, Okuya S & Tanizawa Y (2006). Estrogen receptor a regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J 53, 841-851.
43. Murgia M, Jensen TE, Cusinato M, Garcia M, Richter EA & Schiaffino S (2009). Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J Physiol 587, 4319-4327.
44. Murphy LC, Seekallu SV & Watson PH (2011). Clinical significance of estrogen receptor phosphorylation. Endocr Relat Cancer 18, R1-R14.
45. Nagira K, Sasaoka T, Wada T, Fukui K, Ikubo M, Hori S et al (2006). Altered subcellular distribution of estrogen receptor α is implicated in estradiol-induced dual regulation of insulin signaling in 3T3-L1 adipocytes. Endocrinology 147, 1020-1028.
46. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M et al (1995). Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44, 31-36.
47. Pehmoller C, Treebak JT, Birk JB, Chen S, Mackintosh C, Hardie DG et al (2009). Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 297, E665-E675.
48. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R & Gourdy P (2009). Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150, 2109-2117.
49. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ & Hevener AL (2009). Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient mice. Am J Physiol Endocrinol Metab 298, E304-E319.
50. Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ & Greenberg AS (2009). Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 382, 646-650.
51. Shang Y & Brown M (2002). Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468.
52. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B et al (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331, 1056-1061.
53. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS & Katzenellenbogen JA (2000). Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α-selective agonists. J Med Chem 43, 4934-4947.
54. Stygar D, Masironi B, Eriksson H & Sahlin L (2007). Studies on estrogen receptor (ER) α and β responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists. J Endocrinol 194, 101-119.
55. Treebak JT, Glund S, Deshmukh A, Klein DK, Long YC, Jensen TE et al (2006). AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55, 2051-2058.
56. Vasconsuelo A, Milanesi L & Boland R (2008). 17β-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 196, 385-397.
57. Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA & Cefalu WT (1998). Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab 83, 896-901.
58. Washburn T, Hocutt A, Brautigan DL & Korach KS (1991). Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues. Mol Endocrinol 5, 235-242.
59. Weigel NL (1996). Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319, 657-667.
60. Wohlers LM & Spangenburg EE (2010). 17β-estradiol supplementation attenuates ovariectomy-induced increases in ATGL signaling and reduced perilipin expression in visceral adipose tissue. J Cell Biochem 110, 420-427.
61. Young DA, Uhl JJ, Cartee GD & Holloszy JO (1986). Activation of glucose transport in muscle by prolonged exposure to insulin. Effects of glucose and insulin concentrations. J Biol Chem 261, 16049-16053.